Evidence map›Paper›PMID 42665710›Full record

ReviewNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2026

Glymphatic dysfunction in cerebellar neurodegeneration: mechanistic insights and emerging clinical implications.

Pedro Figueredo Rodriguez, Lorena M Figueredo Rivas, Gladis Rivas Canino

Abstract readReview
PubMed Publisher
In one paragraph

Review in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Pedro Figueredo RodriguezGlyax Medical LLC, 13641 SW 23 Terr, Miami, FL, USA. p49science@gmail.com.ORCID http://orcid.org/0009-0001-9595-6894
Lorena M Figueredo RivasDepartment of Neurology, Cleveland Clinic Florida, Palm Beach Gardens, FL, USA.ORCID http://orcid.org/0009-0004-4863-0033
Gladis Rivas CaninoGlyax Medical LLC, 13641 SW 23 Terr, Miami, FL, USA.ORCID http://orcid.org/0009-0002-0429-7107

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeThe glymphatic system is a glial-dependent perivascular clearance pathway that maintains central nervous system homeostasis through cerebrospinal fluid and interstitial fluid exchange. Emerging evidence suggests that glymphatic dysfunction contributes to the pathophysiology of neurodegenerative disorders involving cerebellar networks. This review summarizes current evidence linking glymphatic dysfunction to cerebellar neurodegeneration, with a particular focus on spinocerebellar ataxia type 3, multiple system atrophy, progressive supranuclear palsy, and essential tremor. METHODS AND CONTENT: Mechanistic pathways involving aquaporin-4 mispolarization across astrocytic perivascular and Bergmann glial pial endfeet, neuroinflammation, vascular alterations, and sleep-dependent fluid dynamics are evaluated. Advanced neuroimaging approaches, including diffusion tensor image analysis along the perivascular space (DTI-ALPS), blood oxygen level-dependent-cerebrospinal fluid coupling, and structural perivascular space imaging, are reviewed as complementary surrogate markers of alterations in glymphatic-related fluid dynamics. Recent clinical studies indicate that these glymphatic-related imaging abnormalities correlate with clinical severity and, in specific disorders, may precede overt symptom onset.

conclusionsCollectively, current evidence supports glymphatic dysfunction as a contributor to cerebellar neurodegeneration and related movement disorders. A deeper understanding of glymphatic clearance dynamics may facilitate the development of novel imaging biomarkers and targeted therapeutic strategies addressing impaired protein clearance, reactive astrogliosis, vascular dysfunction, and sleep disturbances.

Indexed as

Cerebellar DiseasesGlymphatic SystemNeurodegenerative DiseasesAnimalsHumansAquaporin-4DTI-ALPSGlymphatic systemNeurodegenerationNeuroimagingSpinocerebellar ataxia

Identifiers

PMID42665710

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.